Ronald Park

Ronald Park is an accomplished leader in the life sciences and biotechnology sectors, currently serving as an Entrepreneur in Residence at Third Rock Ventures since May 2023. Park has held significant roles including Board Director at Dark Horse Consulting Group Inc. and Advisory Board Member at Paceline. As CEO and President of Ambys Medicines from May 2021 to November 2022, Park led the development of innovative cell therapies and secured a $47M Series A extension. Previous positions include General Manager and EVP of Health and Genomics at Ancestry and Global Head for Personalized Healthcare at Roche, where contributions included the co-founding of Roche’s PHC Center of Excellence. Park's extensive background also features roles at Genentech and McKinsey & Company, alongside academic appointments at UCLA Medical Center. Educational qualifications include an MBA from Stanford University, an MD from Stanford University School of Medicine, and a BA in Biology from Harvard University.